|
|
.
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 (CM) Code and Descriptor
|
R16.0 |
Hepatomegaly, not elsewhere classified
|
R160 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 27.11%
|
23.86%
|
16.13%
|
10.09%
|
6.26%
|
4.12%
|
3.04%
|
2.28%
|
1.62%
|
1.35%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R16.0*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
6,006
|
6,034
|
|
80053
|
COMPREHEN METABOLIC PANEL |
4,169
|
4,169
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
4,055
|
4,057
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
4,018
|
373,603
|
|
76705
|
ECHO EXAM OF ABDOMEN |
3,852
|
3,865
|
|
74183
|
MRI ABD W/O CNTR FLWD CNTR |
3,822
|
3,822
|
|
85610
|
PROTHROMBIN TIME |
3,492
|
3,497
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
3,411
|
3,424
|
|
76700
|
US EXAM ABDOM COMPLETE |
2,744
|
2,745
|
|
47000
|
NEEDLE BIOPSY OF LIVER PERQ |
2,003
|
2,014
|
|
82565
|
ASSAY OF CREATININE |
1,938
|
1,939
|
|
J3010
|
FENTANYL CITRATE INJECTION |
1,901
|
2,930
|
|
G1004
|
CDSM NDSC |
1,879
|
2,038
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
1,862
|
1,862
|
|
J2250
|
INJ MIDAZOLAM HYDROCHLORIDE |
1,781
|
4,397
|
|
88341
|
IMHCHEM/IMCYTCHM EA ADD ANTB |
1,755
|
7,203
|
|
88307
|
TISSUE EXAM BY PATHOLOGIST |
1,675
|
1,721
|
|
82105
|
ALPHA-FETOPROTEIN SERUM |
1,659
|
1,659
|
|
88342
|
IMHCHEM/IMCYTCHM 1ST ANTB |
1,464
|
1,619
|
|
85027
|
COMPLETE CBC AUTOMATED |
1,239
|
1,245
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R16.0 related to the following DRG Codes:
441-443
|
